论文部分内容阅读
茶苯海明是一种抗组胺类药,是治疗晕动病的有效药物,具有显著的民用和军事应用价值。本文检索PubMed、the Cochrane Ear,Nose and Throat Disorders Group Trials Register、the Cochrane Central Register of Controlled Trials、EMBASE、CINAHL、Web of Science、BIOSIS Previews等数据库,归纳所有可获得的文献,综合分析茶苯海明治疗晕动病的安全性和有效性。结果显示,尽管治疗晕动病的首选药物是东莨菪碱,但茶苯海明是治疗晕动病伴发恶心和呕吐时的首选药物。这可能与茶苯海明能减少晕动刺激过程中胃的运动有关。因此在治疗伴有恶心和呕吐症状的晕动病时,应首选茶苯海明。
Benzene diphenhydramine is an antihistamine, is an effective drug for the treatment of motion sickness, with significant civilian and military applications. This paper searches PubMed, the Cochrane Ear, Nose and Throat Disorders Group Trials Register, the Cochrane Central Register of Controlled Trials, EMBASE, CINAHL, Web of Science, BIOSIS Previews and other databases to summarize all the available literature, Treatment of motion sickness safety and effectiveness. The results showed that although the preferred drug for the treatment of motion sickness is scopolamine, methotrexate is the drug of choice for the treatment of nausea and vomiting associated with motion sickness. This may be related to the reduction of dysentery in the process of vigorous stimulation of the gastric motility. Therefore, the treatment of nausea and vomiting associated with motion sickness, should be the preferred choice of Chandan.